Subject: (Reuss) Re EMF/diabetes...... (fwd) Date: Sat, 29 Aug 1998 023746 -0500 (CDT) From: "Roy L. Beavers" <rbeavers@mail.llion.org> To: emfguru@hotmail.com -------------------------------------------------- ---------- Forwarded message ---------- Date: Sat, 29 Aug 1998 01:07:19 +0200 From: Christoph ReussTo: "Roy L. Beavers" Subject: (Reuss) Re: EMF/diabetes...... (fwd) On Thu, 27 Aug 1998, Roger Coghill wrote: > I have read somewhere that electricians have above average diabetes rates. > Anyone know of a supporting study for this? I have an opposing census study [1] for this: In Switzerland, the Comparative Mortality Figure (CMF) for electricians is 62.7 for diabetes (that's very low -- it means that while the expected number (from the age-adjusted general population) of diabetes deaths is 100, only 62.7 electricians actually died of diabetes in the examined time period (1979-83). However, electricians' CMF for pancreatic malignoma is a high 170.3. Some professions with a high CMF for diabetes are: Profession: CMF: a. wood industry jobs except carpenters 139.3 b. butchers 141.3 c. leather industry 156.1 d. stones/ceramics/glass processing 196.8 e. bakers/pastry-cooks 203.5 f. textile manufacture 227.0 g. cooks 235.8 It seems that these are professions that are either pre-disposed by diet (b,e,g) or by dealing with preservation and other endocrine-disrupting chemicals (a,c,d,f) -- there is evidence that the latter are involved in the etiology of diabetes. A Medline search brought up two studies [2,3] that mention that EMFs are used in the TREATMENT of diabetes ! But this seems to be restricted to mere treatment of symptoms (e.g. neuropathy), not cause-oriented treatment... Cheerio, Chris References: [1] Profession-specific mortality risks of men in Switzerland 1979-83. Volume 14: Health. Swiss Federal Office for Statistics, 1997. (All men were aged 35-74) [2] Beneficial effects of electromagnetic fields. Bassett CA, Bioelectric Research Center, Columbia University, Riverdale, New York 10463. J Cell Biochem, 1993 Apr, 51:4, 387-93 Abstract: Selective control of cell function by applying specifically configured, weak, time-varying magnetic fields has added a new, exciting dimension to biology and medicine. Field parameters for therapeutic, pulsed electromagnetic field (PEMFs) were designed to induce voltages similar to those produced, normally, during dynamic mechanical deformation of connective tissues. As a result, a wide variety of challenging musculoskeletal disorders have been treated successfully over the past two decades. More than a quarter million patients with chronically ununited fractures have benefitted, worldwide, from this surgically non-invasive method, without risk, discomfort, or the high costs of operative repair. Many of the athermal bioresponses, at the cellular and subcellular levels, have been identified and found appropriate to correct or modify the pathologic processes for which PEMFs have been used. Not only is efficacy supported by these basic studies but by a number of double-blind trials. As understanding of mechanisms expands, specific requirements for field energetics are being defined and the range of treatable ills broadened. These include nerve regeneration, wound healing, graft behavior, diabetes, and myocardial and cerebral ischemia (heart ^^^^^^^^ attack and stroke), among other conditions. Preliminary data even suggest possible benefits in controlling malignancy. [3] Pulsed electromagnetic fields in experimental cutaneous wound healing in rats. Patiņo O; Grana D; Bolgiani A; Prezzavento G; Miņo J; Merlo A; Benaim F Department of Postgraduate Reconstructive and Plastic Surgery, Universidad del Salvador and Fundacion del Quemado. J Burn Care Rehabil, 1996 Nov, 17:6 Pt 1, 528-31 Abstract: Electromagnetic fields are now being used in many diseases such as osseous, ligamental, cartilaginous, or nervous reparation, diabetes, and myocardial or cerebral ischemia. [...] ^^^^^^^^ Archive provided courtesy of WaveGuide, http://www.wave-guide.org Reprinted with permission of Roy Beavers, http://www.feb.se/EMF-L/EMF-L.html